On Friday, July 31, 2026, CMS finalized its FY 2027 inpatient hospital payment rule. Buried in the usual mix of rate updates and quality-program tweaks is a policy that deserves the industry’s full attention: CJR-X, a nationwide, mandatory, episode-based payment model for joint replacements. Taken together with the rule’s other provisions, it suggests that episode-based accountability continues to move from selected markets toward broader mandatory participation and that the relevant unit of payment increasingly extends beyond the hospital stay itself.
What changed, at a glance
- CJR-X will make joint replacement episodes mandatory nationwide starting January 1, 2028 — holding most acute care hospitals accountable for cost and quality across the 90 days after discharge.
- Hospitals receive a 2.3% Medicare payment increase in FY 2027, below the 2.4% proposed and the 2.6% granted for FY 2026. Long-term care hospitals also get 2.3%.
— Quality measurement expands to Medicare Advantage patients across several mortality and acute-care-use measures.
- A new sepsis readmission measure will begin affecting hospital payments in FY 2030.
- Electronic prior authorization becomes optional in 2027 and mandatory in 2028 under the Promoting Interoperability Program.
Episode accountability goes nationwide
The final rule expands the Comprehensive Care for Joint Replacement (CJR) Model, tested regionally for years, into a new model called CJR-X. Beginning January 1, 2028, it will be mandatory across the country for hip, knee, and ankle replacements performed in inpatient hospitals or hospital outpatient departments. Hospitals will be accountable for Medicare spending and quality across a begining with the procedure and extending through 90 days after discharge.
The mechanics are familiar from earlier bundled-payment work: CMS sets a target price for each episode. Keep spending below the target while meeting quality requirements, and a hospital may earn additional payment. Exceed it, and the hospital may owe money back to Medicare. CMS finalized several provider protections: refined risk adjustment, a policy for lower-volume hospitals, and lower stop-loss limits, while carving out hospitals in the mandatory TEAM Model and Maryland’s all-payer system.
The significance is less about joint replacements specifically and more about the direction of travel. CJR-X reinforces the path TEAM established. Where TEAM applies to selected procedures and geographies starting in 2026, CJR-X brings nationwide episode accountability to joint replacements two years later, a pattern that points toward wider mandatory participation over time.
A modest bump that won’t settle the debate
CMS finalized a 2.3% increase in inpatient hospital payment rates for FY 2027, reflecting a projected 3.2% market-basket increase reduced by a 0.9 percentage-point productivity adjustment. The agency estimates the changes will raise inpatient payments by roughly $2.1 billion. Long-term care hospitals receive a matching 2.3% standard-rate update.
The number lands below the 2.4% CMS proposed in April and the 2.6% hospitals received for FY 2026, and hospital groups have already called it inadequate against operating costs. Add-on payments for Medicare-dependent and low-volume hospitals are set to expire December 31, 2026 unless Congress acts. For many organizations, the update may reinforce the growing importance of the episode-based and value programs alongside traditional fee-for-service payment.
Quality measurement widens to Medicare Advantage
CMS finalized a notable expansion of Medicare Advantage data within its hospital quality programs. Starting with the FY 2028 payment determination, MA beneficiaries will be included in three measures of excess days in acute care following heart attack, heart failure, and pneumonia, and in five mortality measures spanning those conditions plus COPD and coronary artery bypass graft surgery — measures later folded into Hospital Value-Based Purchasing. CMS is also shortening several performance periods from three years to two so results reflect more recent performance.
This is a quiet but meaningful shift. With MA now more than half of Medicare enrollment, CMS is beginning to build a more complete view of hospital performance by incorporating MA patients into measures that historically relied primarily on traditional Medicare data. For organizations measuring hospital and post-acute performance, the change further increases the value of seeing across both MA and traditional Medicare populations.
Sepsis readmissions tighten the post-acute link
CMS finalized a new 30-day, all-cause readmission measure following hospitalization for sepsis, which will begin affecting payment reductions in FY 2030. Sepsis patients are often clinically complex and frequently need home health, skilled nursing, or rehabilitation after discharge. The measure sharpens hospitals’ incentive to plan discharges well, select post-acute partners deliberately, and prevent avoidable returns, exactly the coordination that episode models reward.
Prior authorization goes electronic
CMS finalized changes making electronic prior authorization part of the Medicare Promoting Interoperability Program, an optional bonus measure for the 2027 reporting period, mandatory beginning in 2028. Over time, faster electronic authorization could reduce the administrative delays that slow transitions into home health, SNF, DME, and infusion care. Organizations that can connect claims, referral, payer, and provider data will be best positioned to spot those delays and keep patients moving.
The through-line: performance across the full episode
Read together, these policies appear to move in a consistent direction. CMS is gradually extending the boundary of hospital accountability toward what happens after discharge, and it is expanding the measurement infrastructure, across MA and traditional Medicare, across conditions, and across 90-day windows, that would support it. As fee-for-service rates continue to receive relatively modest annual updates, hospitals’ financial performance will increasingly be shaped by episode-based and value-based payment programs as well.
For hospitals, success under CJR-X puts greater financial weight behind
questions that fee-for-service never forced them to answer: which post-acute providers receive their joint replacement referrals, how those providers differ on SNF length of stay, home health use, readmissions, and total episode spend, and which consistently deliver strong outcomes at a sustainable cost. For post-acute providers, preferred relationships will increasingly hinge on the ability to demonstrate performance across the whole episode, not simply to deliver an individual servic
That creates a significant data and analytics challenge before it is a clinical or contracting one. Both sides of the referral will need market-specific insight into referral patterns, discharge destinations, provider performance, readmissions, length of stay, and utilization during the 90-day episode. The organizations that connect fragmented data into a clear view of the full continuum and embed that intelligence into everyday workflows are likely to be better positioned as CJR-X takes effect in 2028. With the rule now finalized, the period ahead offers time to build that market-level understanding.
Sources: CMS FY 2027 IPPS/LTCH PPS Final Rule — CMS Fact Sheet, CMS Press Release, and Final Rule.
